{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:12:18Z","timestamp":1792843938411,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:00:00Z","timestamp":1774742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009408","name":"Brain Canada Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009408","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000261","name":"Multiple Sclerosis Society of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000023","name":"Government of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Quebec Health Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005155","name":"Azrieli Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neurol.2026.03.007","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:11:02Z","timestamp":1775247062000},"page":"447-454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Contrasting genetic architectures of multiple sclerosis susceptibility and outcome phenotypes"],"prefix":"10.1016","volume":"182","author":[{"given":"M.Y.","family":"Sorella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ygonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.M.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2616-7274","authenticated-orcid":false,"given":"A.","family":"Harroud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2026.03.007_bib0345","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(23)01473-3","article-title":"Multiple sclerosis","volume":"403","author":"Jakimovski","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2026.03.007_bib0350","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0355","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/brain\/awt356","article-title":"Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden","volume":"137","author":"Westerlind","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2026.03.007_bib0360","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/jech.39.1.39","article-title":"Sib risk and the dizygotic twin concordance rate for multiple sclerosis","volume":"39","author":"James","year":"1985","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.neurol.2026.03.007_bib0365","series-title":"The genetics of multiple sclerosis. Multiple sclerosis: perspectives in treatment and pathogenesis","first-page":"3","author":"Didonna","year":"2017"},{"key":"10.1016\/j.neurol.2026.03.007_bib0370","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1177\/1352458514564492","article-title":"Twin studies in multiple sclerosis: a meta-estimation of heritability and environmentality","volume":"21","author":"Fagnani","year":"2015","journal-title":"Mult Scler J"},{"key":"10.1016\/j.neurol.2026.03.007_bib0375","doi-asserted-by":"crossref","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","article-title":"Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility","volume":"365","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.neurol.2026.03.007_bib0380","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1126\/science.adg2992","article-title":"Common genetic factors among autoimmune diseases","volume":"380","author":"Harroud","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.neurol.2026.03.007_bib0385","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/brain\/awac092","article-title":"Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans","volume":"146","author":"Shams","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2026.03.007_bib0390","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1177\/1352458521995484","article-title":"The relative contributions of obesity, vitamin D, leptin, and adiponectin to multiple sclerosis risk: a Mendelian randomization mediation analysis","volume":"27","author":"Harroud","year":"2021","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2026.03.007_bib0395","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41586-023-06388-8","article-title":"From target discovery to clinical drug development with human genetics","volume":"620","author":"Trajanoska","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2026.03.007_bib0400","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-024-07316-0","article-title":"Refining the impact of genetic evidence on clinical success","volume":"629","author":"Minikel","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2026.03.007_bib0405","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/jama.2025.1604","article-title":"High-dose vitamin D in clinically isolated syndrome typical of multiple sclerosis: the D-Lay MS randomized clinical trial","volume":"333","author":"Thouvenot","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2026.03.007_bib0410","doi-asserted-by":"crossref","first-page":"101957","DOI":"10.1016\/j.eclinm.2023.101957","article-title":"High-dose vitamin D supplementation in relapsing-remitting multiple sclerosis: a randomised clinical trial","volume":"59","author":"Cassard","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.neurol.2026.03.007_bib0415","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41586-023-06250-x","article-title":"Locus for severity implicates CNS resilience in progression of multiple sclerosis","volume":"619","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2026.03.007_bib0420","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1038\/s41588-025-02342-8","article-title":"Limited overlap between genetic effects on disease susceptibility and disease survival","volume":"57","author":"Yang","year":"2025","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2026.03.007_bib0425","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.2015.3435","article-title":"Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response","volume":"313","author":"Viatte","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2026.03.007_bib0430","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/s41588-021-00901-3","article-title":"The distribution of common-variant effect sizes","volume":"53","author":"O\u2019Connor","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2026.03.007_bib0435","article-title":"Oligodendroglia as functional effectors of multiple sclerosis risk variants","author":"Carlstr\u00f6m","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.neurol.2026.03.007_bib0440","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/ng.3395","article-title":"Class I.I. HLA interactions modulate genetic risk for multiple sclerosis","volume":"47","year":"2015","journal-title":"Nature Genetics"},{"key":"10.1016\/j.neurol.2026.03.007_bib0445","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/13524585211053155","article-title":"A higher burden of multiple sclerosis genetic risk confers an earlier onset","volume":"28","author":"Misicka","year":"2022","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2026.03.007_bib0450","doi-asserted-by":"crossref","first-page":"e200159","DOI":"10.1212\/NXG.0000000000200159","article-title":"Adaptive and innate immunity are key drivers of age at onset of multiple sclerosis","volume":"10","author":"Misicka","year":"2024","journal-title":"Neurol Genet"},{"key":"10.1016\/j.neurol.2026.03.007_bib0455","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1212\/NXG.0000000000000087","article-title":"Multiple sclerosis risk loci and disease severity in 7125 individuals from 10 studies","volume":"2","author":"George","year":"2016","journal-title":"Neurol Genet"},{"key":"10.1016\/j.neurol.2026.03.007_bib0460","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1212\/NXI.0000000000000129","article-title":"Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction","volume":"2","author":"Esposito","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2026.03.007_bib0465","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1001\/jamaneurol.2016.0980","article-title":"Association of HLA genetic risk burden with disease phenotypes in multiple sclerosis","volume":"73","author":"Isobe","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0470","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2026.03.007_bib0475","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/ana.26061","article-title":"Genetic variation in WNT9B increases relapse hazard in multiple sclerosis","volume":"89","author":"Vandebergh","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0480","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.msard.2017.01.015","article-title":"Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity","volume":"13","author":"S\u00f8ndergaard","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2026.03.007_bib0485","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S1474-4422(22)00255-1","article-title":"Genetics of multiple sclerosis: lessons from polygenicity","volume":"21","author":"Goris","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0490","doi-asserted-by":"crossref","first-page":"fcad255","DOI":"10.1093\/braincomms\/fcad255","article-title":"Genetic influences on disease course and severity, 30 years after a clinically isolated syndrome","volume":"5","author":"Sahi","year":"2023","journal-title":"Brain Commun"},{"key":"10.1016\/j.neurol.2026.03.007_bib0495","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1177\/1352458514568174","article-title":"Burden of risk variants correlates with phenotype of multiple sclerosis","volume":"21","author":"Hilven","year":"2015","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2026.03.007_bib0500","doi-asserted-by":"crossref","first-page":"103452","DOI":"10.1016\/j.msard.2021.103452","article-title":"Neuroimaging predictors of longitudinal disability and cognition outcomes in multiple sclerosis patients: a systematic review and meta-analysis","volume":"57","author":"Pike","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2026.03.007_bib0505","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/brain\/awn301","article-title":"Genotype\u2013phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures","volume":"132","author":"Okuda","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2026.03.007_bib0510","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1038\/s41598-021-81035-8","article-title":"Quantitative MRI phenotypes capture biological heterogeneity in multiple sclerosis patients","volume":"11","author":"Smets","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurol.2026.03.007_bib0515","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jamaneurol.2016.4329","article-title":"HLA genetic risk burden in multiple sclerosis","volume":"73","author":"M\u00fchlau","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0520","doi-asserted-by":"crossref","first-page":"14313","DOI":"10.1038\/s41598-023-41099-0","article-title":"Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials","volume":"13","author":"Loomis","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.neurol.2026.03.007_bib0525","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/13524585221130941","article-title":"influences long-term disability progression and tissue damage on MRI in relapse-onset multiple sclerosis","volume":"29","author":"Brownlee","year":"2023","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2026.03.007_bib0530","doi-asserted-by":"crossref","first-page":"e200499","DOI":"10.1212\/NXI.0000000000200499","article-title":"Genetic risk variants for multiple sclerosis and other loci linked to intrathecal immunoglobulin G synthesis","volume":"12","author":"Pukaj","year":"2025","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2026.03.007_bib0535","doi-asserted-by":"crossref","first-page":"e64408","DOI":"10.1371\/journal.pone.0064408","article-title":"Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients","volume":"8","author":"Leone","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neurol.2026.03.007_bib0620","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1093\/brain\/awz188","article-title":"Early complement genes are associated with visual system degeneration in multiple sclerosis","volume":"142","author":"Fitzgerald","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2026.03.007_bib0540","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1212\/01.wnl.0000252822.53506.46","article-title":"Familial effects on the clinical course of multiple sclerosis","volume":"68","author":"Hensiek","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2026.03.007_bib0545","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/jnnp.71.6.757","article-title":"Multiple sclerosis in sibling pairs: an analysis of 250 families","volume":"71","author":"Chataway","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2026.03.007_bib0550","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2026.03.007_bib0555","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1177\/1352458517690618","article-title":"Age Related Multiple Sclerosis Severity Score: disability ranked by age","volume":"23","author":"Manouchehrinia","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2026.03.007_bib0560","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1177\/13524585241240406","article-title":"No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry","volume":"30","author":"Campagna","year":"2024","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2026.03.007_bib0565","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.26831","article-title":"Relevance of multiple sclerosis severity genotype in predicting disease course: a real-world cohort","volume":"95","author":"Kreft","year":"2024","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0570","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1177\/13524585241264472","article-title":"Genetics of multiple sclerosis severity: the importance of statistical power in replication studies","volume":"30","author":"Harroud","year":"2024","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2026.03.007_bib0575","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/brain\/awac449","article-title":"Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity","volume":"146","author":"Jokubaitis","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2026.03.007_bib0580","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/gene.2011.34","article-title":"Genome-wide association study of severity in multiple sclerosis","volume":"12","year":"2011","journal-title":"Genes Immun"},{"key":"10.1016\/j.neurol.2026.03.007_bib0585","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jnnp-2018-318360","article-title":"Assessing the long-term effectiveness of interferon-beta and glatiramer acetate in multiple sclerosis: final 10-year results from the UK multiple sclerosis risk-sharing scheme","volume":"90","author":"Palace","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2026.03.007_bib0590","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/ana.26807","article-title":"A genetic risk variant for multiple sclerosis severity is associated with brain atrophy","volume":"94","author":"Gasperi","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0595","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/acn3.70157","article-title":"The rs10191329 risk allele is associated with pronounced retinal layer atrophy in multiple sclerosis","volume":"12","author":"Bsteh","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0600","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/ana.27144","article-title":"Increased disability progression in rs10191329 carriers with multiple sclerosis is preceded by neurofilament light chain elevations","volume":"97","author":"Protopapa","year":"2025","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0605","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamaneurol.2023.3997","article-title":"Neurofilament light chain elevation and disability progression in multiple sclerosis","volume":"80","author":"Abdelhak","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0610","doi-asserted-by":"crossref","first-page":"112430","DOI":"10.1016\/j.isci.2025.112430","article-title":"Multiple sclerosis severity variant in locus associates with neuronal loss and inflammation","volume":"28","author":"Engelenburg","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.neurol.2026.03.007_bib0615","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1038\/s41467-025-58274-8","article-title":"Enabling new insights from old scans by repurposing clinical MRI archives for multiple sclerosis research","volume":"16","author":"Goebl","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.neurol.2026.03.007_bib0625","doi-asserted-by":"crossref","first-page":"e200212","DOI":"10.1212\/NXI.0000000000200212","article-title":"Complement activation is associated with disease severity in multiple sclerosis","volume":"11","author":"Oechtering","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2026.03.007_bib0630","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/clpt.2011.355","article-title":"Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B genotype and abacavir dosing","volume":"91","author":"Martin","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.neurol.2026.03.007_bib0635","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/s41588-018-0168-y","article-title":"Common variation near IRF6 is associated with IFN-\u03b2-induced liver injury in multiple sclerosis","volume":"50","author":"Kowalec","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2026.03.007_bib0640","doi-asserted-by":"crossref","first-page":"105873","DOI":"10.1016\/j.ebiom.2025.105873","article-title":"HLA-A*03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis","volume":"118","author":"Zhang","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.neurol.2026.03.007_bib0645","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1974","article-title":"Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity","volume":"8","author":"Dendrou","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurol.2026.03.007_bib0650","series-title":"Sudo Biosciences announces positive Phase 1 results for brain-penetrant allosteric TYK2 inhibitor SUDO-550","year":"2025"},{"key":"10.1016\/j.neurol.2026.03.007_bib0655","doi-asserted-by":"crossref","first-page":"ofaa450","DOI":"10.1093\/ofid\/ofaa450","article-title":"Genetic determinants of antibody-mediated immune responses to infectious diseases agents: a genome-wide and HLA association study","volume":"7","author":"Butler-Laporte","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.neurol.2026.03.007_bib0660","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-023-06618-z","article-title":"Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations","volume":"625","author":"Barrie","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2026.03.007_bib0665","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ana.25323","article-title":"Expanded disability status scale progression assessment heterogeneity in multiple sclerosis according to geographical areas","volume":"84","author":"Bovis","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0670","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ana.27112","article-title":"Obesity and multiple sclerosis severity: a Mendelian randomization study","volume":"97","author":"Alzamanan","year":"2024","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0675","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41582-022-00704-y","article-title":"Towards a global view of multiple sclerosis genetics","volume":"18","author":"Jacobs","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2026.03.007_bib0680","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537872600500X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537872600500X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:14:11Z","timestamp":1792674851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537872600500X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S003537872600500X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2026.03.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contrasting genetic architectures of multiple sclerosis susceptibility and outcome phenotypes","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2026.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}